Manipulating T Cells to Treat Patients With Cancer - Targeted Oncology

Bruce Feinberg, DO, explains how chimeric antigen receptor T cells were introduced in hematologic malignancies.

Bruce Feinberg, DO, vice president and chief medical officer at Cardinal Health Specialty Solutions, explains how the exploration of chimeric antigen receptor (CAR) T cells began. In the 1980s, many… [+1877 chars]

full article...